ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001
December 02, 2021Valneva a specialty vaccine company, and IDT Biologika announced their collaboration for the production of Valneva’s inactivated COVID-19 vaccine candidate VLA2001. This follows last week’s announcement that Valneva signed an Advance Purchase Agreement... -
Takeda and IDT Support Manufacturing of J&J’s COVID-19 Vaccine
March 16, 2021Takeda Pharmaceutical has entered a mutual agreement with IDT Biologika GmbH, a contract development and manufacturing organization (CDMO), to utilize capacity at IDT previously reserved for Takeda’s dengue vaccine candidate (TAK-003) to manufacture ... -
IDT Biologika Awarded New NIH Task Order
July 18, 2019Part of 10-year NIH contract to manufacture vaccines and biologics for infectious diseases. -
NIH grants IDT 10-year vaccine manufacturing contract
December 04, 2018IDT Biologika has won a 10-year contract worth up to $80 million from the NIH’s National Institute of Allergy and Infectious Diseases to make vaccines and biologics for infectious diseases.
Pharma Sources Insight January 2025
